Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Stiles Spencer SOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Stiles Spencer SOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,796Price:$353.19
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Stiles Spencer SOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Pierce James AndrewOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Pierce James AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-4,412Price:$353.19
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Pierce James AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Menon VijuOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-158Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Menon VijuOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,444Price:$353.19
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Menon VijuOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:158Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Lobo KevinOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-905Price:--
Filings by filing date
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Stiles Spencer SOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Stiles Spencer SOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,796Price:$353.19
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Stiles Spencer SOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Pierce James AndrewOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Pierce James AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-4,412Price:$353.19
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Pierce James AndrewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:203Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Menon VijuOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-158Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Menon VijuOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-3,444Price:$353.19
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Menon VijuOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:158Price:--
-
Mar 21, 2024 (filed on Mar 25, 2024)Insider Name:Lobo KevinOwnership Type:Direct OwnershipSecurities:Dividend EquivalentsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-905Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 2825 Airview Blvd KALAMAZOO MI 49002 |
Tel: | N/A |
Website: | https://www.stryker.com |
IR: | See website |
Key People | ||
Kevin A. Lobo Chairman of the Board, President, Chief Executive Officer | Glenn S. Boehnlein Chief Financial Officer, Vice President | Viju S. Menon Group President - Global Quality and Operations |
J. Andrew Pierce Group President - MedSurg and Neurotechnology | Spencer S. Stiles Group President - Orthopaedics and Spine | M. Kathryn Fink Chief Human Resource Officer, Vice President |
William E. Berry Chief Accounting Officer, Vice President | Yin C. Becker Vice President - Chief Corporate Affairs Officer | Robert S. Fletcher Vice President, Chief Legal Officer |
Business Overview |
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. It also offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. |
Financial Overview |
For the three months ended 31 March 2024, Stryker Corp revenues increased 10% to $5.24B. Net income increased 33% to $788M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Regulatory and legal matters decrease of 94% to $2M (expense), Restructuring-related and other charges decrease of 73% to $11M (expense). |
Employees: | 52,000 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $133,240M as of Mar 31, 2024 |
Annual revenue (TTM): | $20,963M as of Mar 31, 2024 |
EBITDA (TTM): | $5,518M as of Mar 31, 2024 |
Net annual income (TTM): | $3,361M as of Mar 31, 2024 |
Free cash flow (TTM): | $1,699M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $8,400M as of Mar 31, 2024 |
Shares outstanding: | 380,469,830 as of Mar 31, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |